Rocket Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs f…
Biotechnology
US, Cranbury [HQ]

Balance Sheet

12 Sheets · From 2023 to 2012
Configuration
In Million USD. Margins, Growth Rates In %
Metric 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
1.00 12.00 5.00 113.00 129.00 101.00 251.00 372.00 590.00 497.00 551.00 566.00
Current
1.00 12.00 3.00 112.00 128.00 101.00 209.00 307.00 487.00 392.00 364.00 378.00
Non Current
- - - - 1.00 - - 1.00 - - 42.00 64.00 103.00 104.00 187.00 188.00
Liabilities
32.00 51.00 57.00 4.00 56.00 54.00 57.00 64.00 87.00 42.00 62.00 73.00
Current
3.00 3.00 3.00 4.00 7.00 4.00 15.00 18.00 32.00 22.00 39.00 48.00
Non Current
28.00 48.00 53.00 - - 49.00 49.00 41.00 46.00 54.00 20.00 22.00 25.00
Equity
-30.00 -38.00 -51.00 108.00 73.00 47.00 194.00 307.00 503.00 454.00 489.00 492.00
Stockholders' Equity
-30.00 -38.00 -51.00 108.00 73.00 47.00 194.00 307.00 503.00 454.00 489.00 492.00
Retained Earnings
-110.00 -118.00 -128.00 -196.00 -238.00 -268.00 -105.00 -183.00 -322.00 -491.00 -713.00 -959.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
28.00 41.00 46.00 113.00 - - 41.00 - - - - - - - - - - - -
Profit
-6.00 -7.00 -9.00 -67.00 -42.00 -29.00 -74.00 -83.00 -146.00 -169.00 -219.00 -245.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
51.00 38.00 29.00 191.00 311.00 274.00 299.00 489.00 825.00 946.00 1,203.00 1,450.00
Loss Other Compr. Income
- - - - - - - - - - - - - - - - - - - - - - - -